News

Precision Optics Launches Revolutionary Unity Imaging Platform

GARDNER, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation (Nasdaq: POCI), a global leader in the design and…

11 months ago

Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and…

11 months ago

Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe’s $3.6 Billion Drug Screening Market and in Middle Eastern Regions

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical…

11 months ago

Better Choice Company Signs Non-Binding Term Sheet to Sell Halo Asia for $6.5 Million in Cash at Closing and a 5-Year Royalty Valued at a Minimum of $1.65 Million

Upon closing, Better Choice will retain ownership of North American and rest-of-world ex Asia operations Buyer has paid a $500,000…

11 months ago

BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs

Advancement of next-generation APJ agonists with discontinuation of azelaprag Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial…

11 months ago

New Survey from Aeroflow Sleep Reveals Disparities Around Women’s Sleep Health

The proprietary survey found 60% of women feel their sleep is negatively impacting their day-to-day activities, yet more than half…

11 months ago

Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump

Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planningNEW YORK,…

11 months ago

Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases

Dual-Targeted CD19/CD70 Allogeneic CAR T: Best-in-Class Design to Enhance Therapeutic Benefit and Expand Treatment Potential Across a Range of Autoimmune…

11 months ago

Eterna Therapeutics Announces Expansion of Scientific Advisory Board

Dr. Jerome Zeldis and Dr. Blythe Sather bring exceptional backgrounds in cell therapy and solid tumorsCAMBRIDGE, Mass., Jan. 28, 2025…

11 months ago

Silexion Therapeutics Reports Strong Tumor Growth Reduction from Systemic Administration of SIL-204 in Preclinical Pancreatic Cancer Models

New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating inhibition of tumor growth in a…

11 months ago